Views | |
---|---|
Tisagenlecleucel (chimeric antigen receptor T-cells targeting CD19) for patients with relapsed/refractory B-cell acute lymphoblastic leukemia: asystematic review and cost-utility analysis from a Spanish perspective | 349 |
June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | |
---|---|---|---|---|---|---|---|
Tisagenlecleucel (chimeric antigen receptor T-cells targeting CD19) for patients with relapsed/refractory B-cell acute lymphoblastic leukemia: asystematic review and cost-utility analysis from a Spanish perspective | 7 | 0 | 5 | 26 | 0 | 3 | 0 |
Views | |
---|---|
Delgado_Tisagenlecleucel_MUESIOL.pdf | 150 |
Views | |
---|---|
United States | 139 |
Spain | 55 |
Germany | 20 |
France | 9 |
Switzerland | 6 |
Saudi Arabia | 6 |
Vietnam | 6 |
United Arab Emirates | 5 |
Brazil | 5 |
Canada | 5 |
Views | |
---|---|
San Ramon | 25 |
Barcelona | 17 |
Madrid | 13 |
Redwood City | 12 |
Boardman | 11 |
Fremont | 9 |
Ann Arbor | 8 |
Hamburg | 7 |
Mountain View | 6 |
Ashburn | 5 |